Seven out of 10 advisers believe that VCT investments can sit alongside ISAs and pensions, according to a report by Intelligent Partnership. We’ve pulled together a few highlights from the January 2017 report: In total 82 per cent of advisers recommend VCTs to clients, up from 67 per cent from last year’s survey, which the … Continued
Calculus Capital has welcomed the government’s pledge to boost Britain’s expanding life sciences and technology industries after the Prime Minister met the Chief Scientist behind one of its investee companies during a landmark visit to the North West. Theresa May used the visit to the Northern Powerhouse, where she held her first Cabinet meeting outside … Continued
Scancell Holdings Plc has inked a US collaboration deal with a leading lung cancer foundation that will accelerate the development of a ground-breaking immuno-oncology drug. It is teaming up with the Addario Lung Cancer Medical Institute (ALCMI) and the Bonnie J Addario Lung Cancer Foundation to take its SCIB2 cancer vaccine in phase I/II clinical trials. … Continued
UK group to supply kits to detect biological warfare agents The FT reports that Genedrive has clinched a rare deal with the US armed forces, providing them with millions of pounds of kit to test for biological warfare agents. The US Department of Defense has now begun field trials of DNA analysis equipment from Genedrive. … Continued
EIS and VCTs increasingly on investors’ radar John Glencross, Chief Executive, Calculus Capital looks at the reasons – most notably the scaling back of pension tax relief over recent years – why EIS and VCTs are appearing on the radar of an increasing number of investors Pensions are not what they used to be; certainly … Continued
Private equity fund manager and Enterprise Investment Scheme (EIS) and Venture Capital Trust (VCT) specialist Calculus Capital has invested £3m in Origin Broadband, an award-winning provider of internet and phone services. Since launch in 2011, Origin has developed its own infrastructure and now has the sixth largest broadband network in the UK based on ‘premises passed’. … Continued
Calculus Capital has invested £3m in cleantech firm Weedingtech, which is focused on replacing toxic herbicides. Weedingtech is a world leader in herbicide-free weed and moss control, and has earned multiple awards for sustainable innovation. The company was co-founded by environmental campaigner and entrepreneur Ben Goldsmith. Calculus has invested in the business in recognition of … Continued
Calculus Capital’s portfolio company Synpromics, the leading synthetic promoter and gene control company, announced a research collaboration with GE Healthcare to jointly develop customised synthetic promoters optimised for GE Healthcare’s proprietary biopharmaceutical manufacturing platform. Synpromics will develop a complex bar-coded library of synthetic promoters, using its proprietary PromPT™ platform, for extensive screening in GE Healthcare’s Chinese … Continued
Oxford-based WheelRight’s tyre monitoring technology is being used as part of a US ‘highway of the future’ project. 21 December 2016, Transport Engineer. The live project covers an 18-mile stretch – dubbed ‘The Ray’ – on interstate 85 from Georgia to Alabama, and aims to demonstrate how US interstates can eliminate deaths, waste and carbon. … Continued
Calculus Capital’s portfolio company InspireSport have recorded a record-breaking month for tour bookings. Steve Butchart, CEO, InspireSport: “It’s been a record breaking two months for inspiresport. November was the biggest single booking month for the company since its formation in 2004, while October represented the largest single month for volume of tours departing. These two … Continued